# Biomarkers

DRAGEN biomarker support is tabulated below. Please refer to the respective sections for details on requirements and how to configure each module.

|                                                                                                                                                     | WES T/N                         | WES T/O                    | WGS T/N                  | WGS T/O   |
| --------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------- | -------------------------- | ------------------------ | --------- |
| [HRD](https://help.dragen.illumina.com/product-guides/dragen-v4.5/dragen-dna-pipeline/biomarkers/biomarker-hrd)                                     | Supported                       | Supported                  | Supported                | Supported |
| [MSI](https://help.dragen.illumina.com/product-guides/dragen-v4.5/dragen-dna-pipeline/biomarkers/biomarker-msi)                                     | Supported                       | Supported                  | Supported                | Supported |
| [TMB](https://help.dragen.illumina.com/product-guides/dragen-v4.5/dragen-dna-pipeline/biomarkers/biomarker-tmb)                                     | Supported                       | Supported                  | Supported                | Supported |
| [Fragmentomics](https://help.dragen.illumina.com/product-guides/dragen-v4.5/dragen-dna-pipeline/biomarkers/biomarker-fragmentomics)                 | Unsupported                     | Supported                  | Unsupported              | Supported |
| [Mutational Signatures](https://help.dragen.illumina.com/product-guides/dragen-v4.5/dragen-dna-pipeline/biomarkers/biomarker-mutational-signatures) | Unsupported<sup>\[1],\[2]</sup> | Unsupported<sup>\[2]</sup> | Supported<sup>\[1]</sup> | Supported |

***

<sup>\[1]</sup> All Tumor/Normal workflows automatically perform mutational signatures analysis with no additional options required.

<sup>\[2]</sup> WES sequences \~1% of the genome compared to WGS, resulting in \~1% of the somatic mutations available for analysis. While analysis execution is possible, it is not recommended; results are likely not reliable with such limited input.


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://help.dragen.illumina.com/product-guides/dragen-v4.5/dragen-dna-pipeline/biomarkers.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.